Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.07
-0.07 (-0.98%)
At close: Dec 5, 2025, 4:00 PM EST
7.21
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:50 PM EST
Bicycle Therapeutics Employees
Bicycle Therapeutics had 305 employees as of December 31, 2024. The number of employees increased by 21 or 7.39% compared to the previous year.
Employees
305
Change (1Y)
21
Growth (1Y)
7.39%
Revenue / Employee
$92,915
Profits / Employee
-$821,836
Market Cap
490.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCYC News
- 23 days ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire
- 5 weeks ago - Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Bicycle Therapeutics: Looking For Their Niche, Addressing Cash Burn - Seeking Alpha
- 3 months ago - Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Bicycle Therapeutics Strengthens Board of Directors with New Appointments - Business Wire
- 4 months ago - Bicycle (BCYC) Q2 Revenue Falls 69% - The Motley Fool
- 4 months ago - Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results - Business Wire
- 5 months ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire